Impact of Family History and Decision Support on High-risk Cancer Screening
Status: | Enrolling by invitation |
---|---|
Conditions: | Colorectal Cancer, Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 40 - 64 |
Updated: | 3/7/2019 |
Start Date: | August 1, 2017 |
End Date: | March 31, 2020 |
Family health history can help identify patients at higher than average risk for disease.
There is no standardized system for collecting and updating family health history, using this
information to determine a patient's disease risk level, and providing screening
recommendations to patients and providers. Patients will enter their family health history
into MeTree, a family history software program. The program will produce screening
recommendations tailored to the patient's family health history. The investigators will
examine whether this process increases physician referrals for, and patient uptake of,
guideline-recommended screening for colorectal cancer.
There is no standardized system for collecting and updating family health history, using this
information to determine a patient's disease risk level, and providing screening
recommendations to patients and providers. Patients will enter their family health history
into MeTree, a family history software program. The program will produce screening
recommendations tailored to the patient's family health history. The investigators will
examine whether this process increases physician referrals for, and patient uptake of,
guideline-recommended screening for colorectal cancer.
Eligible patients are aged 40-65 years, enrolled in primary care, do not have a personal
history of colorectal cancer, and have some knowledge of family health history. In Aim 1, a
retrospective chart review will be conducted to determine the baseline rate of documenting
family health history of colorectal cancer in the medical record for patients enrolled in the
Aim 2 randomized trial. In Aim 2, consented patients will be randomized to provide
patient-entered family health history and receive patient and provider decision support at
enrollment or 12 months later (wait-list control). The primary outcome is risk-appropriate
CRC screening/surveillance referral for patients 12 months post-enrollment. Secondary
outcomes include patient uptake of recommendations and referral for genetic consultation 12
months post-enrollment. In Aim 3, qualitative interviews will be conducted with physicians
and clinic leaders; data will be analyzed using conventional content analysis. In Aim 4, data
will be obtained from the administrative databases and patient medical records to conduct a
budget impact analysis.
history of colorectal cancer, and have some knowledge of family health history. In Aim 1, a
retrospective chart review will be conducted to determine the baseline rate of documenting
family health history of colorectal cancer in the medical record for patients enrolled in the
Aim 2 randomized trial. In Aim 2, consented patients will be randomized to provide
patient-entered family health history and receive patient and provider decision support at
enrollment or 12 months later (wait-list control). The primary outcome is risk-appropriate
CRC screening/surveillance referral for patients 12 months post-enrollment. Secondary
outcomes include patient uptake of recommendations and referral for genetic consultation 12
months post-enrollment. In Aim 3, qualitative interviews will be conducted with physicians
and clinic leaders; data will be analyzed using conventional content analysis. In Aim 4, data
will be obtained from the administrative databases and patient medical records to conduct a
budget impact analysis.
Inclusion Criteria:
Primary care provider inclusion criteria:
- primary care physician,
- physician assistant, or nurse practitioner;
- at least one half-day of primary care clinic per week.
Patient inclusion criteria:
- assigned to an enrolled PCP;
- English as preferred language;
- no plans to relocate or leave the VA system in the next 12 months;
- at least one primary care appointment in the 18 months prior to enrollment;
- upcoming PCP appointment with assigned PCP;
- aged 40-64 years; no previous history of colorectal cancer or adenomatous polyps or
inflammatory bowel disease;
- no endoscopy within previous 3 years; some knowledge of family health history
Exclusion Criteria:
n/a (contained within inclusion criteria)
We found this trial at
2
sites
Madison, Wisconsin 53705
Phone: 919-286-6936
Click here to add this to my saved trials
Click here to add this to my saved trials